The immunopharmacology of cyclophosphamide
- 8 November 2002
- journal article
- review article
- Published by Elsevier
- Vol. 1 (3) , 165-171
- https://doi.org/10.1016/0192-0561(79)90038-9
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Drug‐promoted B cell tolerance induction: a selective activity of cyclophosphamide dependent on the tolerogenicity of thymus‐independent antigensEuropean Journal of Immunology, 1978
- Influence of molecular structure on the tolerogenicity of bacterial dextransEuropean Journal of Immunology, 1977
- Timely appraisal: Ectopic (exocellular) nucleic acid as a drug target, especially in rheumatoid arthritis and certain cancers (?)Inflammation Research, 1975
- Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.The Journal of Experimental Medicine, 1975
- THE EFFECT OF CYTOTOXIC DRUGS ON GRAFT-VERSUS-HOST DISEASE IN MICETransplantation, 1971
- Specific Tolerance to Sheep Erythrocytes in Mouse Bone Marrow CellsNature, 1969
- Enhancement of Dinitrochlorobenzene (DNCB) Contact Sensitization by Cyclophosphamide in the Guinea PigJournal of Investigative Dermatology, 1967
- SUPPRESSION OF TISSUE IMMUNITY BY CYCLOPHOSPHAMIDETransplantation, 1964
- Cadaveric Renal TransplantationBMJ, 1963
- Drug-induced Immunological ToleranceNature, 1959